Mr. Eugene Francis Moynihan Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 131 S Bicycle Path, Selden, NY 11784 Phone: 631-698-2155 Fax: 631-698-2155 |
Jennifer Vetter Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3 Denise Ct, Selden, NY 11784 Phone: 631-846-8070 |
Mrs. Virginia Lois Medina-lomas, LCSW-R Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1305 Middle Country Rd Ste 14d, Selden, NY 11784 Phone: 631-833-8266 |
Mr. Michael J. Greenberg, LCSW-R, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1305 Middle Country Rd, Suite 7, Selden, NY 11784 Phone: 631-754-3158 |
Julie Lomot, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25 N Bicycle Path, Selden, NY 11784 Phone: 631-285-8819 |
Ms. Cathy J Oliva, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6 Texas St, Selden, NY 11784 Phone: 631-846-1889 |
Irsah Shahzad Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 95 Sunset Ave, Selden, NY 11784 Phone: 631-482-0593 |
Georgette Morales, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 Paula Blvd, Selden, NY 11784 Phone: 631-404-5060 |
Mrs. Lauren Elizabeth Lara, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 17 Eagle St, Selden, NY 11784 Phone: 631-374-6143 |
News Archive
Scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, have developed a new method for studying gene regulation, by employing a jumping gene as an informant. Published online today in Nature Genetics, the new method is called GROMIT.
A new preprint describes an effort to describe the risk factors for severe COVID-19 in children.
Using supercomputers to respond to a potential national health emergency, scientists have developed a simulation model that makes stark predictions about the possible future course of an avian influenza pandemic, given today's environment of worldwide connectivity.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada's special access program, this was only the third time this new type of ICD had been implanted in Canada.
› Verified 4 days ago